Danaher (DHR) Higher, Sees Q4 EPS Exceeding Previous Guidance

January 9, 2013 3:11 PM EST
Danaher Corporation (NYSE: DHR) shares have been higher all session following a regulatory filing earlier.

The company said CEO H. Lawrence Culp, Jr., will be presenting at the J.P. Morgan Healthcare Conference today and it expects to exceed the high-end of previous fourth-quarter 2012 EPS guidance.

Shares are up 3.6 percent on the session.

The full release is below.


Danaher Corporation announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company’s performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company’s fourth quarter 2012 diluted net earnings per share is anticipated to be above the high end of the previously announced range of $0.80-0.85, with higher than expected core revenue growth in the quarter.

*** The Street consensus calls for Q412 EPS of $0.83.

Mr. Culp stated: “We are pleased by the strong finish to the year from both a revenue and earnings perspective, which was broad-based across most of our businesses.”


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Guidance, Insiders' Blog

Related Entities

JPMorgan, Earnings